Clinical Note
November 2000

Methicillin-Resistant Staphylococcus aureusPediatric Otitis

Author Affiliations

From the Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, and the Department of Otology and Laryngology, Harvard Medical School, Boston, Mass (Mr Santos and Drs Mankarious, and Eavey). Mr Santos is now with Weill Cornell Medical College, New York, NY.


Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000

Arch Otolaryngol Head Neck Surg. 2000;126(11):1383-1385. doi:10.1001/archotol.126.11.1383

Background  Methicillin-resistant Staphylococcus aureus (MRSA) is a potentially lethal organism in pediatric patients. MRSA is an uncommon otologic pathogen that requires special diagnostic and therapeutic intervention.

Methods  Three pediatric patients with community-acquired MRSA otologic infections were identified during 1999.

Setting  Tertiary care ear institution.

Results  All patients required intravenous antibiotic therapy to achieve resolution of the infections.

Conclusions  MRSA in children can be community acquired and can cause otitis externa, otitis media with otorrhea, or acute mastoiditis; intravenous therapy that includes vancomycin is necessary for resolution.